Original Article

You have full text access to this OnlineOpen article

Estrogens attenuate oxidative stress and the differentiation and apoptosis of osteoblasts by DNA-binding-independent actions of the ERα

  1. Maria Almeida,
  2. Marta Martin-Millan,
  3. Elena Ambrogini,
  4. Robert Bradsher III,
  5. Li Han,
  6. Xiao-Dong Chen,
  7. Paula K Roberson,
  8. Robert S Weinstein,
  9. Charles A O'Brien,
  10. Robert L Jilka,
  11. Stavros C Manolagas*

Article first published online: 14 DEC 2009

DOI: 10.1359/jbmr.091017

Issue

Journal of Bone and Mineral Research

Journal of Bone and Mineral Research

Volume 25, Issue 4, pages 769–781, April 2010

Additional Information

How to Cite

Almeida, M., Martin-Millan, M., Ambrogini, E., Bradsher, R., Han, L., Chen, X.-D., Roberson, P. K., Weinstein, R. S., O'Brien, C. A., Jilka, R. L. and Manolagas, S. C. (2010), Estrogens attenuate oxidative stress and the differentiation and apoptosis of osteoblasts by DNA-binding-independent actions of the ERα. J Bone Miner Res, 25: 769–781. doi: 10.1359/jbmr.091017

Author Information

  1. Division of Endocrinology and Metabolism, Center for Osteoporosis and Metabolic Bone Diseases, University of Arkansas for Medical Sciences and the Central Arkansas Veterans Health Care System, Little Rock, AR, USA

*4301 West Markham, No. 587, Little Rock, AR 72205-7199, USA.

Publication History

  1. Issue published online: 9 APR 2010
  2. Article first published online: 14 DEC 2009
  3. Accepted manuscript online: 27 JAN 2010 12:00AM EST
  4. Manuscript Accepted: 9 OCT 2009
  5. Manuscript Revised: 31 JUL 2009
  6. Manuscript Received: 27 MAR 2009

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (597K)

References

  • 1
    Manolagas SC. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev. 2000; 21: 115–137.
  • 2
    Manolagas SC, Kousteni S, Jilka RL. Sex steroids and bone. Recent Prog Horm Res. 2002; 57: 385–409.
  • 3
    Manolagas SC, Kousteni S, Chen JR, Schuller M, Plotkin L, Bellido T. Kinase-mediated transcription, activators of nongenotropic estrogen-like signaling (ANGELS), and osteoporosis: a different perspective on the HRT dilemma. Kidney Int Suppl. 2004; 91: S41–49.
  • 4
    Jilka RL, Hangoc G, Girasole G, et al. Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science. 1992; 257: 88–91.
  • 5
    DiGregorio G, Yamamoto M, Ali A, et al. Attenuation of the self-renewal of transit amplifying osteoblast progenitors in the murine bone marrow by 17β-estradiol. J Clin Invest. 2001; 107: 803–812.
  • 6
    Kousteni S, Bellido T, Plotkin LI, et al. Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell. 2001; 104: 719–730.
  • 7
    Kousteni S, Chen J-R, Bellido T, et al. Reversal of bone loss in mice by nongenotropic signaling of sex steroids. Science. 2002; 298: 843–846.
  • 8
    Kousteni S, Han L, Chen J-R, et al. Kinase-mediated regulation of common transcription factors accounts for the bone-protective effects of sex steroids. J Clin Invest. 2003; 111: 1651–1664.
  • 9
    Chen JR, Plotkin LI, Aguirre JI, et al. Transient Versus Sustained Phosphorylation and Nuclear Accumulation of ERKs Underlie Anti-Versus Pro-apoptotic Effects of Estrogens. J Biol Chem. 2005; 280: 4632–4638.
  • 10
    Jilka RL, Takahashi K, Munshi M, Williams DC, Roberson PK, Manolagas SC. Loss of estrogen upregulates osteoblastogenesis in the murine bone marrow: evidence for autonomy from factors released during bone resorption. J Clin Invest. 1998; 101: 1942–1950.
  • 11
    Usui M, Yoshida Y, Tsuji K, et al. Tob deficiency superenhances osteoblastic activity after ovariectomy to block estrogen deficiency-induced osteoporosis. Proc Natl Acad Sci U S A. 2004; 101: 6653–6658.
  • 12
    Yamamoto T, Saatcioglu F, Matsuda T. Cross-talk between bone morphogenic proteins and estrogen receptor signaling. Endocrinology. 2002; 143: 2635–2642.
  • 13
    Kousteni S, Almeida M, Han L, Bellido T, Jilka RL, Manolagas SC. Induction of osteoblast differentiation by selective activation of kinase-mediated actions of the estrogen receptor. Mol Cell Biol. 2007; 27: 1516–1530.
  • 14
    Rosen V. BMP and BMP inhibitors in bone. Ann N Y Acad Sci. 2006; 1068: 19–25.
    Direct Link:
  • 15
    Canalis E, Economides AN, Gazzerro E. Bone morphogenetic proteins, their antagonists, and the skeleton. Endocr Rev. 2003; 24: 218–235.
  • 16
    Yamaguchi A, Komori T, Suda T. Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfa1. Endocr Rev. 2000; 21: 393–411.
  • 17
    Abe E, Yamamoto M, Taguchi Y, et al. Essential requirement of BMPs-2/4 for both osteoblast and osteoclast formation in murine bone marrow cultures from adult mice: antagonism by noggin. J Bone Miner Res. 2000; 15: 663–673.
    Direct Link:
  • 18
    Massague J, Seoane J, Wotton D. Smad transcription factors. Genes Dev. 2005; 19: 2783–2810.
  • 19
    Shi Y, Massague J. Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell. 2003; 113: 685–700.
  • 20
    Feng XH, Derynck R. Specificity and versatility in TGF-β signaling through Smads. Annu Rev Cell Dev Biol. 2005; 21: 659–693.
  • 21
    Sapkota G, Alarcon C, Spagnoli FM, Brivanlou AH, Massague J. Balancing BMP signaling through integrated inputs into the Smad1 linker. Mol Cell. 2007; 25: 441–454.
  • 22
    Kretzschmar M, Doody J, Massagué J. Opposing BMP and EGF signalling pathways converge on the TGF-β family mediator Smad1. Nature. 1997; 389: 618–622.
  • 23
    Pera EM, Ikeda A, Eivers E, De Robertis EM. Integration of IGF, FGF, and anti-BMP signals via Smad1 phosphorylation in neural induction. Genes Dev. 2003; 17: 3023–3028.
  • 24
    Aubin J, Davy A, Soriano P. In vivo convergence of BMP and MAPK signaling pathways: impact of differential Smad1 phosphorylation on development and homeostasis. Genes Dev. 2004; 18: 1482–1494.
  • 25
    Almeida M, Han L, Martin-Millan M, et al. Skeletal involution by age-associated oxidative stress and its acceleration by loss of sex steroids. J Biol Chem. 2007; 282: 27285–27297.
  • 26
    Giorgio M, Migliaccio E, Orsini F, et al. Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell. 2005; 122: 221–233.
  • 27
    Jakacka M, Ito M, Martinson F, Ishikawa T, Lee EJ, Jameson JL. An estrogen receptor (ER) α deoxyribonucleic acid-binding domain knock-in mutation provides evidence for nonclassical ER pathway signaling in vivo. Mol Endocrinol. 2002; 16: 2188–2201.
  • 28
    Korchynskyi O, Ten Dijke P. Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter. J Biol Chem. 2002; 277: 4883–4891.
  • 29
    Dupont S, Krust A, Gansmuller A, Dierich A, Chambon P, Mark M. Effect of single and compound knockouts of estrogen receptors α (ERα) and β (ERβ) on mouse reproductive phenotypes. Development. 2000; 127: 4277–4291.
  • 30
    Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids: potential mechanisms of their deleterious effects on bone. J Clin Invest. 1998; 102: 274–282.
  • 31
    Weinstein RS, Chen JR, Powers CC, et al. Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids. J Clin Invest. 2002; 109: 1041–1048.
  • 32
    Fuentealba LC, Eivers E, Ikeda A, et al. Integrating patterning signals: Wnt/GSK3 regulates the duration of the BMP/Smad1 signal. Cell. 2007; 131: 980–993.
  • 33
    Jilka RL, Weinstein RS, Bellido T, Parfitt AM, Manolagas SC. Osteoblast programmed cell death (apoptosis): modulation by growth factors and cytokines. J Bone Miner Res. 1998; 13: 793–802.
    Direct Link:
  • 34
    Kuznetsov S, Robey PG. Species differences in growth requirements for bone marrow stromal fibroblast colony formation in vitro. Calcif Tissue Int. 1996; 59: 265–270.
  • 35
    Kian TM, Rogatsky I, Tzagarakis-Foster C, et al. Estradiol and selective estrogen receptor modulators differentially regulate target genes with estrogen receptors α and β. Mol Biol Cell. 2004; 15: 1262–1272.
  • 36
    Almeida M, Han L, Bellido T, Manolagas SC, Kousteni S. Wnt proteins prevent apoptosis of both uncommitted osteoblast progenitors and differentiated osteoblasts by β-catenin-dependent and -independent signaling cascades involving Src/ERK and phosphatidylinositol 3-kinase/AKT. J Biol Chem. 2005; 280: 41342–41351.
  • 37
    Huang X, Frenkel K, Klein CB, Costa M. Nickel induces increased oxidants in intact cultured mammalian cells as detected by dichlorofluorescein fluorescence. Toxicol Appl Pharmacol. 1993; 120: 29–36.
  • 38
    Plotkin LI, Weinstein RS, Parfitt AM, Roberson PK, Manolagas SC, Bellido T. Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. J Clin Invest. 1999; 104: 1363–1374.
  • 39
    Jilka RL, Weinstein RS, Takahashi K, Parfitt AM, Manolagas SC. Linkage of decreased bone mass with impaired osteoblastogenesis in a murine model of accelerated senescence. J Clin Invest. 1996; 97: 1732–1740.
  • 40
    Syed F, Modder U, Fraser D, et al. Skeletal effects of estrogen are mediated by opposing actions of classical and non-classical estrogen receptor pathways. J Bone Miner Res. 2005; 20: 1992–2001.
    Direct Link:
  • 41
    Kuroda H, Fuentealba L, Ikeda A, Reversade B, De Robertis EM. Default neural induction: neuralization of dissociated Xenopus cells is mediated by Ras/MAPK activation. Genes Dev. 2005; 19: 1022–1027.
  • 42
    Hall JM, Couse JF, Korach KS. The Multifaceted Mechanisms of Estradiol and Estrogen Receptor Signaling. J Biol Chem. 2001; 276: 36869–36872.
  • 43
    Manolagas SC, Kousteni S. Perspective: Nonreproductive Sites of Action of Reproductive Hormones. Endocrinology. 2001; 142: 2200–2204.
  • 44
    Hammes SR, Levin ER. Extranuclear steroid receptors: nature and actions. Endocr Rev. 2007; 28: 726–741.
  • 45
    Sims NA, Dupont S, Krust A, et al. Deletion of estrogen receptors reveals a regulatory role for estrogen receptors-β in bone remodeling in females but not in males. Bone. 2002; 30: 18–25.
  • 46
    Antal MC, Krust A, Chambon P, Mark M. Sterility and absence of histopathological defects in nonreproductive organs of a mouse ERβ-null mutant. Proc Natl Acad Sci USA. 2008; 105: 2433–2438.
  • 47
    Li Y, Li A, Strait K, Zhang H, Nanes MS, Weitzmann MN. Endogenous TNFα lowers maximum peak bone mass and inhibits osteoblastic Smad activation through NF-κB. J Bone Miner Res. 2007; 22: 646–655.
    Direct Link:
  • 48
    Smith EP, Specker B, Bachrach BE, et al. Impact on Bone of an Estrogen Receptor-α Gene Loss of Function Mutation. J Clin Endocrinol Metab. 2008; 93: 3088–3096.
  • 49
    Bab I, Hajbi-Yonissi C, Gabet Y, Müller R. Tibio-fibular complex and knee joint, Fig. 7. In Micro-Tomographic Atlas of the Mouse Skeleton. New York, NY: Springer, 2007: 177.
  • 50
    De Robertis EM, Kuroda H. Dorsal-ventral patterning and neural induction in Xenopus embryos. Annu Rev Cell Dev Biol. 2004; 20: 285–308.
  • 51
    Niswander L, Martin GR. FGF-4 and BMP-2 have opposite effects on limb growth. Nature. 1993; 361: 68–71.
  • 52
    Neubuser A, Peters H, Balling R, Martin GR. Antagonistic interactions between FGF and BMP signaling pathways: a mechanism for positioning the sites of tooth formation. Cell. 1997; 90: 247–255.
  • 53
    Nakayama K, Tamura Y, Suzawa M, et al. Receptor tyrosine kinases inhibit bone morphogenetic protein-Smad responsive promoter activity and differentiation of murine MC3T3-E1 osteoblast-like cells. J Bone Miner Res. 2003; 18: 827–835.
    Direct Link:
  • 54
    Osyczka AM, Leboy PS. Bone morphogenetic protein regulation of early osteoblast genes in human marrow stromal cells is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase signaling. Endocrinology. 2005; 146: 3428–3437.
  • 55
    Chaudhary LR, Hofmeister AM, Hruska KA. Differential growth factor control of bone formation through osteoprogenitor differentiation. Bone. 2004; 34: 402–411.
  • 56
    Dang ZC, Van Bezooijen RL, Karperien M, Papapoulos SE, Lowik CW. Exposure of KS483 cells to estrogen enhances osteogenesis and inhibits adipogenesis. J Bone Miner Res. 2002; 17: 394–405.
    Direct Link:
  • 57
    Okazaki R, Inoue D, Shibata M, et al. Estrogen promotes early osteoblast differentiation and inhibits adipocyte differentiation in mouse bone marrow stromal cell lines that express estrogen receptor (ER) α or β. Endocrinology. 2002; 143: 2349–2356.
  • 58
    Qu Q, Perälä-Heape M, Kapanen A, et al. Estrogen enhances differentiation of osteoblasts in mouse bone marrow culture. Bone. 1998; 22: 201–209.
View Full Article (HTML) Get PDF (597K)